Product image of Imigran Mite (Sumatriptan) supplied by GNH India

Imigran Mite

Active Ingredient:
Sumatriptan
Origin:
EU

Imigran Mite (Sumatriptan)

Sumatriptan, the active ingredient in Imigran Mite, is a Triptan presented as a nasal spray for nasal use. It treats acute migraine attacks in adults.

GNH India supplies Imigran Mite as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Glaxosmithkline Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Imigran Mite (sumatriptan) is a Triptan indicated for the acute management of migraine and related headache disorders.

  • Migraine: provides rapid relief of headache pain, photophobia, phonophobia and nausea associated with an acute migraine attack.
  • Cluster headache: may abort an acute cluster headache episode when administered early.
  • Acute trigeminal autonomic cephalalgia: can reduce pain intensity in selected patients with short‑lasting attacks.

How It Works

  • Sumatriptan acts as a selective agonist at 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve terminals. Activation causes vasoconstriction of intracranial arteries and inhibits release of pro‑inflammatory neuropeptides, thereby interrupting the pain signaling cascade that underlies migraine attacks.

Side Effects

Common Side Effects

  • Taste disturbance: altered or unpleasant taste after administration.
  • Nasal irritation: burning, stinging or discomfort in the nasal passages.
  • Dizziness: transient light‑headedness or vertigo.
  • Fatigue: feeling unusually tired or weak.
  • Nausea: mild stomach upset or queasiness.
  • Dry mouth: reduced salivation after use.

Serious or Rare Side Effects

  • Chest discomfort or tightness: possible cardiac ischemia.
  • Coronary vasospasm: constriction of heart vessels leading to angina.
  • Severe hypertension: sudden increase in blood pressure.
  • Serotonin syndrome: life‑threatening condition when combined with other serotonergic agents.
  • Allergic reaction: rash, swelling, or anaphylaxis.
  • Severe hypotension: abrupt drop in blood pressure.

Precautions & Warnings

Imigran Mite should be used with caution in patients with specific medical conditions and in conjunction with certain therapies.

  • Cardiovascular assessment: evaluate history of coronary artery disease, angina or stroke before use.
  • Avoid MAO‑inhibitors: do not co‑administer with monoamine oxidase inhibitors or within 14 days of discontinuation.
  • Hypertension monitoring: do not use in uncontrolled high blood pressure.
  • Serotonin syndrome vigilance: watch for symptoms if patient is on SSRIs, SNRIs or other serotonergic drugs.
  • Hypersensitivity check: discontinue if allergic reaction occurs.
  • Store at room temperature: keep in the original package, protect from moisture and heat.

Avoid Interactions

Sumatriptan may interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • MAO inhibitors: increased risk of serotonin syndrome.
  • Other triptans: additive vasoconstrictive effects.
  • Ergot alkaloids: heightened vasospasm risk.
  • SSRIs/SNRIs: potential for serotonin toxicity.
  • Linezolid: similar serotonergic activity.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: may enhance blood pressure lowering.
  • CYP3A4 inhibitors (e.g., ketoconazole): may raise sumatriptan plasma levels.
  • Oral contraceptives: possible increased migraine frequency.
  • NSAIDs: monitor for gastrointestinal irritation.

Frequently Asked Questions

Imigran Mite is a nasal spray formulation of sumatriptan that is prescribed for the acute treatment of migraine attacks. It helps to rapidly relieve headache pain, as well as associated symptoms such as nausea, photophobia and phonophobia, when taken at the first sign of an attack.

Sumatriptan works by selectively stimulating 5‑HT1B and 5‑HT1D receptors in the brain. This action causes constriction of dilated cranial blood vessels and blocks the release of inflammatory neuropeptides from trigeminal nerve endings, thereby interrupting the pain pathway that triggers migraine.

The exact dose of Imigran Mite is determined by the prescribing healthcare professional. The nasal spray typically delivers a fixed amount of sumatriptan per actuation, and the prescriber decides how many sprays are appropriate for each individual patient based on clinical response and safety considerations.

Safety data for sumatriptan in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the Imigran Mite product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Imigran Mite offers a rapid‑onset, non‑oral option compared with tablet formulations of sumatriptan or other triptans. The nasal route bypasses gastrointestinal absorption, which can be advantageous during nausea. Compared with newer CGRP antagonists, sumatriptan has a longer clinical history but may carry higher cardiovascular caution.

Imigran Mite should be stored at room temperature, below 25 °C (77 °F). Keep the spray in its original packaging, protect it from moisture, direct sunlight and excessive heat. Do not freeze the product, and ensure the nozzle is clean before each use.

The medication is delivered as a nasal spray. The patient should gently blow the nose, insert the nozzle into one nostril, and press the actuator to release a spray while breathing in gently. The recommended number of sprays is determined by the prescriber, and the same nostril can be used for subsequent doses if advised.

Serious risks include chest pain or tightness that may signal coronary vasospasm, severe hypertension, serotonin syndrome when combined with other serotonergic drugs, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience any of these symptoms.

Imigran Mite is contraindicated in patients with a history of coronary artery disease, uncontrolled hypertension, peripheral vascular disease, or cerebrovascular disorders. It should also be avoided in individuals who have taken monoamine oxidase inhibitors within the past 14 days, or who are known to be hypersensitive to sumatriptan or any component of the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sumatriptan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT